SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

EU Panel Backs Merck’s Enflonsia for High-Risk Children Through Second RSV Season

Valid market news retained in the public archive without immediate LiveCast distribution.

MRK

Related stories